CMS Proposes New Pathway for Immediate Medicare Coverage of FDA-Approved Devices

CMS issued a procedural notice inviting comment on a proposed pathway to align Medicare coverage determinations with FDA device approvals, potentially enabling immediate coverage for certain breakthrough medical devices upon FDA clearance. The notice seeks stakeholder input on framework design, eligibility criteria, and implementation mechanisms. Comments are due 60 days after Federal Register publication. If finalized, this pathway could reduce coverage uncertainty for medical device manufacturers and accelerate beneficiary access to innovative technologies, though Medicaid coverage determinations remain state-specific and not directly governed by Medicare pathways.